As the Senior Director of Corporate QA and Compliance, Marc is leading the corporate security, quality and compliance initiatives at CRIO. Additionally, he’s serving as CRIO’s Data Protection Officer. Prior to CRIO, Marc was leading the Quality Assurance efforts at snapIoT, now part of Labcorp Drug Development. Before snapIoT, Marc was a key member of the Corporate Compliance and QA group at Clinical Ink from 2012-2021 and served as its Data Protection Officer from 2018 to 2021.
A dynamic senior executive with broad and diverse experience in global management for large public, private, and private equity owned companies, generating millions of dollars in profitable growth. Successful at building, organizing, and directing multi-disciplined teams to develop and deliver innovative solutions to market. A passionate, driven leader with proven ability to adapt to change,...
Prior to co-founding CRIO, Raymond owned and operated a clinical research site. As co-CEO he provides leadership for product development, engineering, and corporate strategy. He has over 10 years of management consulting experience, including The Boston Consulting Group. He also started Bench Core, a real estate data analytics company that was acquired by RefineRE. He...
With 25+ years’ experience, Jonathan Andrus brings extensive expertise developing eClinical services that integrate data and technology to optimize study execution. As co-CEO of CRIO, Jonathan is responsible for customer success, sales, marketing, finance, compliance, and people programs. With CRIO’s focus on reimagining the clinical trial process, Jonathan is committed to driving innovation, reducing site...